%0 Journal Article %A Magda Bucholc %A Paula L. McClean %A Sarah Bauermeister %A Stephen Todd %A Xuemei Ding %A Liam P. Maguire %T Association of the use of hearing aids with the incidence and progression of dementia: A longitudinal retrospective study %D 2020 %R 10.1101/2020.01.31.19015503 %J medRxiv %P 2020.01.31.19015503 %X Background Hearing aid usage has been linked to improvements in cognition, communication, and socialization, but the extent to which it can affect the onset and progression of dementia is unknown. This study leveraged the National Alzheimer’s Coordinating Center Uniform Data Set to longitudinally examine the association between the use of hearing aids and risk of progression from Mild Cognitive Impairment (MCI) to dementia as well as progression of dementia in hearing-impaired adults.Methods The sample included 977 participants aged >50 with MCI or all-cause dementia enrolled between 2005 and 2018. Participants were classified into four groups according to the definition of the duration of disease stage: Group 1, 450 participants with MCI at baseline that developed dementia during follow up; Group 2, 314 participants diagnosed with dementia at baseline and subsequently died during follow-up; Group 3, 126 healthy participants who were later diagnosed with MCI and then dementia at follow-up; Group 4, 87 participants with MCI at baseline who later converted to dementia and subsequently died during follow-up. Groups 3 and 4 were used to better capture the duration of MCI-to-dementia and dementia-to-death periods. Kaplan-Meier survival functions and survival analyses using Cox proportional hazards regression models were performed to assess the effect of hearing aid use on risk of MCI-to-dementia conversion and mortality risk in dementia participants. Sensitivity analyses were performed to control for confounding.Results Hearing aid users with MCI showed a reduced risk of developing dementia both in Group 1 (hazard ratio [HR] 0.56, 95%CI, 0.45-0.69; false discovery rate [FDR] p <.0001) and Group 3 (HR,0.42; 95%CI, 0.27-0.66; FDR p <.001). The mean progression rate in CDRSB was significantly higher for those who did not use hearing aids (p =.04). Hearing aid usage was also found to influence the progression of dementia. Hearing-aid users with dementia had a lower risk of death, both in Group 2 (HR,0.75; 95%CI, 0.60-0.95; FDR p□=.038) and Group 4 (HR,0.53; 95%CI, 0.33-0.89; FDR p□=.04). Our findings were robust subject to multiple sensitivity analyses.Conclusions Among hearing-impaired adults, hearing aid usage was significantly associated with reduced dementia risk and slower disease progression.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was conducted using the National Alzheimer's Coordinating Center resource under application 1026. Authors are supported by the Dr George Moore Endowment for Data Science at Ulster University (Dr Bucholc), EU INTERREG VA Programme (Dr Bucholc, Dr McClean, Dr Todd, Prof Maguire), Alzheimer’s Research UK (Dr Bucholc, Dr McClean, Dr Todd, Dr Ding), European Union Regional Development Fund, Northern Ireland Public Health Agency (Dr McClean), Dementias Platform UK (DPUK) (Dr Bauermeister), and Nutricia, Bohringer-Ingelheim, Genomics Medicine Ireland, Vifor Pharma, and Putnam Associates (Dr Todd).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis research was conducted using the National Alzheimer’s Coordinating Center database under application 1026.ADAlzheimer’s diseaseADCAlzheimer’s Disease CenterCDRSBCDR® Dementia Staging Instrument box scoresCIConfidence intervalFDRFalse discovery rateHRHazard ratioMCIMild Cognitive impairmentNACCNational Alzheimer’s Coordinating CenterUDSUniform Data Set %U https://www.medrxiv.org/content/medrxiv/early/2020/02/03/2020.01.31.19015503.full.pdf